Meropenem Bradex (Meropenem Anhydrous)

Meropenem is a broad‑spectrum carbapenem used to treat severe bacterial infections across several organ systems.

• Complicated intra‑abdominal infections: achieves bacterial eradication and clinical cure.
• Complicated urinary tract infections: clears resistant Gram‑negative pathogens.
• Hospital‑acquired pneumonia: provides effective coverage against multidrug‑resistant organisms.
• Ventilator‑associated pneumonia: restores lung function by eliminating causative bacteria.
• Severe sepsis and septic shock: rapidly reduces bacterial load to support hemodynamic recovery.
• Bacterial meningitis: penetrates the cerebrospinal fluid to eradicate meningitic pathogens.

• Meropenem inhibits bacterial cell wall synthesis by binding with high affinity to penicillin‑binding proteins. This binding disrupts the final transpeptidation step of peptidoglycan cross‑linking, leading to weakened cell walls, osmotic instability, and ultimately bacterial lysis and death. Its broad spectrum includes many Gram‑negative, Gram‑positive, and anaerobic organisms, and it is resistant to most β‑lactamases.

Adverse reactions may vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: may be watery and self‑limiting.
• Rash: erythematous skin eruptions.
• Headache: transient and usually resolves.
• Elevated liver enzymes: mild transaminase increase.
• Injection‑site pain: discomfort at the infusion site.

Serious or Rare Side Effects

• Clostridioides difficile‑associated colitis: severe diarrhea requiring medical attention.
• Anaphylaxis: acute hypersensitivity with respiratory or circulatory collapse.
• Seizures: particularly in patients with renal impairment or high doses.
• Renal toxicity: acute kidney injury in susceptible individuals.
• Severe hypersensitivity reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Careful assessment and monitoring are required before and during therapy.

• Renal impairment: adjust dose based on creatinine clearance.
• Hypersensitivity: discontinue if allergic reaction occurs.
• Pregnancy: use only if potential benefit justifies risk to the fetus.
• Hepatic dysfunction: monitor liver function tests periodically.
• Concomitant nephrotoxic drugs: avoid or monitor renal function closely.
• Store below 25°C: keep in original packaging, protect from moisture and light.

Meropenem may interact with several agents, influencing efficacy or toxicity.

Major Interactions (Avoid)

• Valproic acid: reduces serum levels, risking seizure breakthrough.
• Probenecid: decreases renal clearance, increasing meropenem exposure.
• Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
• Aminoglycosides: additive nephrotoxicity; avoid concurrent high‑dose use.
• Other carbapenems: antagonistic effect on bacterial killing.

Moderate Interactions (Monitor Closely)

• Diuretics: monitor electrolytes and renal function.
• NSAIDs: watch for increased risk of renal impairment.
• Oral contraceptives: possible reduction in efficacy; advise alternative contraception.